Clinical Implications: FLT 3 Mutations and AML
Clinical Implications: FLT 3 Mutations and AML
 |
|
|---|---|
|
Speaker:
Mark Levis, MD, PhD |
|
Description:
This microlearning module discusses the Clinical Implications of the recent and relevant research on FLT 3 Mutations and AML. It is part of the Emerging and Evolving Biomarkers Series
Recording Date: September 28, 2023
Duration: 12 min
Level of Instruction: Intermediate
Note: Join the AMP Family for discounted access to the most current educational resources!
All sales are final. No refunds will be issued.
No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentation.